Trademark Overview
On Monday, July 23, 2018, a trademark application was filed for OMPLIXIS with the United States Patent and Trademark Office. The USPTO has given the OMPLIXIS trademark a serial number of 88048575. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, December 13, 2018. This trademark is owned by Gilead Sciences Ireland UC. The OMPLIXIS trademark is filed in the Pharmaceutical Products category with the following description:
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis